Corrigendum to "Advanced oxidation protein products promote NADPH oxidase-dependent β-cell destruction and dysfunction by a Bcl-2/Bax apoptotic pathway"

Affiliations

¹ State Key Laboratory of Organ Failure Research, National Clinical Research Center of Kidney Disease, Key Clinical Specialty Discipline Construction Program, Division of Nephrology, Nanfang Hospital, Southern Medical University, Guangzhou, China.
² State Key Laboratory of Organ Failure Research, National Clinical Research Center of Kidney Disease, Key Clinical Specialty Discipline Construction Program, Division of Nephrology, Nanfang Hospital, Southern Medical University, Guangzhou, China. Electronic address: ffhouguangzhou@163.com.

Free article

Published Erratum

Min Liang et al. Lab Invest. 2023 Mar.

Free article

. 2023 Mar;103(3):100068.

doi: 10.1016/j.labinv.2023.100068. Epub 2023 Feb 22.

¹ State Key Laboratory of Organ Failure Research, National Clinical Research Center of Kidney Disease, Key Clinical Specialty Discipline Construction Program, Division of Nephrology, Nanfang Hospital, Southern Medical University, Guangzhou, China.
² State Key Laboratory of Organ Failure Research, National Clinical Research Center of Kidney Disease, Key Clinical Specialty Discipline Construction Program, Division of Nephrology, Nanfang Hospital, Southern Medical University, Guangzhou, China. Electronic address: ffhouguangzhou@163.com.

No abstract available

Erratum for

Advanced oxidation protein products promote NADPH oxidase-dependent β-cell destruction and dysfunction through the Bcl-2/Bax apoptotic pathway.
Liang M, Li A, Lou A, Zhang X, Chen Y, Yang L, Li Y, Yang S, Hou FF. Liang M, et al. Lab Invest. 2017 Jul;97(7):792-805. doi: 10.1038/labinvest.2017.24. Epub 2017 Mar 6. Lab Invest. 2017. PMID: 28263293